# Targeting PI3K/AKT/mTOR pathway to enhance the anti-leukemia efficacy of venetoclax

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/targeting-pi3k-akt-mtor-pathway-to-enhance-the-anti-leukemia-efficacy-of/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hongcai Liu,Zubair Hussain,Qingqing Xie,Xueying Yan,Chenxing Zeng,Gan Zhou,Shan Cao |
| Citations | 18 |
| DOI | 10.1016/j.yexcr.2022.113192 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4280545304 |
| PMID | 35568072 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Qingqing Xie](https://scholariq.org/researchers/qingqing-xie/)

## Paper primary topic

- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)

## Paper topics

- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Microtubule and mitosis dynamics](https://scholariq.org/topics/microtubule-and-mitosis-dynamics/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.